OasisLMS

Hepatocellular carcinoma is managed at the intersection of oncology and hepatology, and the decisions rarely belong to one specialty alone. This collection from Medical Learning Institute Inc. brings together on-demand education for the full HCC care team, covering frontline immune checkpoint inhibitor selection, the evolving role of locoregional and immunotherapy combinations, and how liver reserve, tumor burden, and prognostic risk come together in an individualized plan. Activities emphasize applying recently published prospective data to higher-risk populations and strengthening the shared decision-making and monitoring practices that hold multidisciplinary care together. Work through the activities in any order, claim credit as you go, and use the community to bring questions from your own practice to colleagues managing the same patients.